MedPearl
MedPearl is a clinical decision platform built inside Providence and in use there since mid 2022. It helps primary care clinicians decide whether a patient needs a specialist and, if so, which one, how urgently and what workup should come first, using a library of clinician-authored guidance for more than 730 conditions shown inside the electronic health record beside the patient's own data. It was founded by Dr Eve Cunningham, Providence's chief of virtual care and digital health, and a 2024 NEJM Catalyst case study by Providence authors reported productivity, after-hours record time and referral margin improvements across more than 4,000 monthly clinician users.
MedPearl is now sold by Health Endeavors, a technology company for accountable care organizations and value-based care, whose name is on the MedPearl site and whose July 2026 release lists MedPearl in its AI Care Suite, where it also serves as a clinical guardrail for Alex, a virtual care manager that talks with patients. Health Endeavors names Providence and Novant Health as clinical equity partners. No price is published.
Capability Axes
An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read
Artificial intelligence is claimed and no learned component is described. MedPearl's site calls it 'an intelligent clinical decision platform', and Providence's August 2024 release says it was built 'leveraging artificial intelligence and a no-code environment'.
What the same material describes is a library of more than 730 clinician-authored guides, built by clinicians without code, mapped against the patient's own record data and matched to a clinician's query (a 95 percent match rate is reported); none of those functions is described as a trained model, and all of them can be done with authored rules and search.
Health Endeavors, which now sells it, describes MedPearl in July 2026 as 'a clinical decision support library' that acts as a guardrail for its Alex virtual care agent. Trade coverage has headlined it as generative AI at Providence and may describe more.
The oversight structure is described for clinicians and one part is missing. MedPearl delivers 'contextualized next best actions to clinicians', and the clinician decides: whether to refer, to whom and how urgently, and what workup to order, with the guide and the patient's data side by side; the guidance is authored by clinicians.
Health Endeavors now also uses MedPearl as 'a clinical guardrail' for Alex, its virtual care manager that talks with patients and 'alerts care teams when human intervention is needed'. What is not published is what happens when a guide is wrong or missing for a presentation, how guide updates are reviewed and released, and which guides Alex relies on and when Alex hands a patient to a person.
The authoring approach is described in general terms and nothing that produces an output is identified. Providence's August 2024 release describes a library of actionable guidance for more than 730 conditions, built by clinicians in a no-code environment and mapped to record data relevant to the clinical context, with a 95 percent success rate in matching queries to guides; the site adds that it incorporates 'patient data, medical best practices, governance models, and clinical context'. How queries are matched, what 'intelligent' refers to, and whether any model is involved are not described, and no versioning or update practice for guides is published.
The architecture is described and no party in it is named. MedPearl runs inside the record, mapping guides to the patient's data, and is now operated by Health Endeavors, LLC, whose legal pages the MedPearl site links. Health Endeavors' privacy policy says data is stored 'on a secure and encrypted server' and that it is a United States company, and describes its own patient application rather than MedPearl; no hosting provider, subprocessor or model provider is named, and nothing says whether record data surfaced in MedPearl is stored.
Published research short of independent validation, at the health system that built it. MedPearl's site links a NEJM Catalyst case study, 'A Physician-Created Platform to Speed Clinical Decision-Making and Referral Workflow' (2024), by Providence authors; the journal page returns 403 to a fetch, so the figures here come from Providence's August 2024 release describing it: more than 4,000 active monthly clinician users, statistically significant improvement in total productivity, after-hours time in the record and incremental margin per referral among top users, 72 percent of users reporting improved management and workups, a 95 percent query match rate and about 75 percent month-to-month retention.
All of it is from one health system that was also the developer, and the outcomes are operational and financial rather than clinical. One reported benefit, margin per referral, is a revenue measure in a tool that advises whether a patient sees a specialist.
General assurances that do not reach this product. The privacy policy the MedPearl site links is Health Endeavors' own, and it describes a patient application that stores health records and generates health tasks: identifiable data is not shared without consent, data is not sold after identifiers are removed, it sits on 'a secure and encrypted server', and it is deleted when an account ends.
Nothing addresses MedPearl's clinician product: whether record data surfaced beside a guide is stored, what clinician queries are kept, or whether any of it is used to improve the product. Safety engineering, meaning how a wrong or missing guide is caught and handled as a safety event, is not published.
No statement of HIPAA status and no privacy document that reaches the product. The MedPearl site links Health Endeavors' privacy policy and terms, which describe Health Endeavors' own patient-facing application and make no business associate statement; nothing on the MedPearl site or Health Endeavors' pages addresses MedPearl's use of record data inside a health system's chart. The product was built inside Providence, where developer and covered entity were the same, which explains the gap and does not fill it now that another company sells it.
Controls are asserted with nothing independent behind them. The linked Health Endeavors privacy policy says data is kept on a secure and encrypted server; no SOC 2 report, ISO/IEC 27001 or HITRUST certification, penetration test or trust center is named for MedPearl. Health Endeavors' footer links an ONC certification page for its own quality reporting software, which is a different product.
No clearance and no regulatory position is published. MedPearl gives clinicians patient-specific next best actions (whether to refer, to whom, how urgently, what workup), drawn from clinician-authored guides shown beside the patient's own data, so the clinician can read the basis for each suggestion. Health Endeavors now also uses the library as a guardrail for Alex, its patient-facing virtual care manager, which it says works 'without practicing medicine'.
That second use puts library content in front of patients through an agent, which the clinician-facing reasoning does not cover. The founder's appointment as an alternate on the FDA Digital Health Advisory Committee is an individual honor and says nothing about the product's status.
Governance is asserted in general terms with no evaluation. The site says MedPearl incorporates 'governance models', and Providence's release describes guidance built by hundreds of clinicians. No review process for guides, no evaluation of how referral recommendations vary across patient groups, and no results by age, race, language or payer are published. The product advises whether a patient sees a specialist, so guidance that discouraged referral for some groups would restrict access without showing up in productivity measures.
Source traceability is the mechanism, and nothing stands behind the output. Each next best action is a clinician-authored guide shown beside the patient's data, so a clinician can read what the suggestion rests on and depart from it. No accuracy measure for the guidance, no warranty or remediation commitment, and no route for a patient harmed by a wrong suggestion is published; the Health Endeavors terms the site links govern its patient application, not MedPearl.
Integration is claimed and in production at one system, with no record system named. Providence's August 2024 release says that 'combined with EMR integration, MedPearl has been adopted across Providence's eight-state footprint', delivering guidance beside the patient's record data on one screen, and the MedPearl contact form asks which EMR platform a prospect runs. The company names no record system, standard, marketplace listing or second deployment.
Delivered inside the record at Providence, with location implied rather than committed. MedPearl is now sold by Health Endeavors, a United States company whose privacy policy mentions a secure, encrypted server; no hosting provider, region, tenancy model or data residency position is stated for MedPearl, and no deployment outside Providence is described.
No price is published, and how it is sold can be partly established. MedPearl's site is a single page with a contact form, and Health Endeavors' July 2026 release sells it inside an AI Care Suite for accountable care organizations and value-based care, alongside its Alex virtual care manager and OmniView patient profiles. What drives the cost is not stated. The published evaluation reports incremental margin per referral as a benefit, which suggests the value case rests on referral economics.
Coverage is stated clearly for one setting at one system: primary care clinicians deciding whether and how to involve a specialist, across more than 730 conditions, in use across Providence's eight-state footprint since 2022. Health Endeavors now places it in value-based care and accountable care programs and behind a patient-facing agent. Nothing validates the guidance outside Providence, in other referral networks or payer mixes, or in the patient-facing use.
Alternatives to MedPearl
Vendors in the same categories as MedPearl whose graded profiles look most alike, with a line on what each product does.
Similar is not the same, so check that each one does the job you need. No vendor pays for placement.
Clinical pathway authoring and governance platform that turns a health system's guidelines, protocols and policies into structured, visual decision logic delivered inside the EHR.
AI4Eyes is building OSDx, a compact imaging device that mounts on a clinic's slit lamp and consolidates ten dry eye tests into one five minute scan, paired with subscription AI software…
Creyos, formerly Cambridge Brain Sciences and briefly Creyos Health, is a Toronto company selling digital cognitive and behavioral health assessment to clinicians.
Azra AI reads pathology and radiology reports as they land in the record and turns what it finds into work someone is accountable for.
Nest Genomics, the trading name of Nest Health Inc. and a Y Combinator company, sells a genomic care platform that runs inside the electronic health record.
Japanese health technology company with two AI products.
Ordered by how closely the graded profiles match across the fifteen axes, inside the same categories. See how each axis is graded in the methodology.
Compared With
Each comparison carries a written verdict, the buyer conditions that favor each vendor, and a graded side by side. Pairs that cross a category boundary are grouped separately, and their verdicts state where the boundary sits rather than manufacturing a head to head.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Not published
|
Not published. Sold by Health Endeavors within an AI Care Suite for accountable care and value-based care; the published evaluation reports margin per referral as a benefit. | Not published. No business associate statement appears on the MedPearl site or Health Endeavors' pages; the product was built where developer and covered entity were the same. | Not published. No deployment outside Providence is described. | Vendor Published |
MedPearl's site is a single page with a contact form, and Health Endeavors publishes no price for the suite or its parts. Ask whether MedPearl is sold alone, the unit of charge, which referrals any value model counts and whether it assumes referrals stay in network, and which Health Endeavors entity contracts.